Example: Heart Attack

Clinical Trials Sponsored by Eisai Korea Inc

Total 23 results

NCT03448445

Active, not recruiting

A Study to Evaluate Alzheimer's Disease Conversion Rate Differences Between High-risk Mild Cognitive Impairment (MCI) and Low-risk MCI in a Real World Setting

Conditions: Mild Cognitive Impairment
NCT03437083

Completed

A Study to Investigate the Efficacy and Safety of Eribulin in Korean Breast Cancer Participants

Conditions: Locally Advanced or Metastatic Breast Cancer
NCT03264703

Completed

Study in Patients With Moderated to Severe Rheumatoid Arthritis Who Have Failed to Combination Therapy of Conventional Disease-modifying Antirheumatic Drugs (cDMARDs) to cDMARD Plus ANti-TNF Versus cDMARDs in Real World

Conditions: Arthritis, Rheumatoid
NCT03264690

Completed

Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients

Conditions: Inflammatory Bowel Disease
NCT02764554

Recruiting

Post-Marketing Surveillance of Lenvima in Korean Patients

Conditions: Differentiated Thyroid Carcinoma (DTC)
NCT02726074

Completed

Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures With or Without Secondary Generalization

Conditions: Epilepsy
NCT02722590

Recruiting

Post-Marketing Surveillance Study of Fycompa Film-coated Tablets in Korean Patients

Conditions: Epilepsy
NCT02441764

Completed

Halaven Post-Marketing Surveillance (PMS)

Conditions: Breast Cancer
NCT02434484

Completed

Symbenda Post-Marketing Surveillance (PMS)

Conditions: Lymphoma, Non-Hodgkin; Lymphocytic Leukemia; Multiple Myeloma
NCT02262975

Completed

A Multi-national Study to Identify Treatment Discontinuation Rate in de Novo Alzheimer's Disease Patients Who Have Been Newly Prescribed With Donepezil (Aricept) in Asia (ADOS)

Conditions: Alzheimer's Disease
NCT02158910

Completed

A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients

Conditions: Alzheimer's Disease
NCT02097056

Completed

Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease

Conditions: Alzheimer's Disease
NCT01961544

Completed

Eribulin Mesylate Phase IV Clinical Trial in Korean Patients With Metastatic or Locally Advanced Breast Cancer

Conditions: Breast Neoplasms; Breast Cancer
NCT01140867

Completed

Open-label, Multi-center Trial of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy

Conditions: Epilepsy
NCT01127256

Completed

Comparative Study of Zonisamide and Carbamazepine as an Initial Monotherapy: Efficacy and Safety Evaluation

Conditions: Epilepsy
NCT01127165

Completed

Low and High Dose Zonisamide in Children as Monotherapy

Conditions: Epilepsy
NCT00381381

Completed

The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease

Conditions: Alzheimer's Disease
NCT00165750

Terminated

Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients

Conditions: Alzheimer's Disease
NCT00165724

Completed

Alzheimer's Disease Long-term Follow-up Study (ALF Study)

Conditions: Alzheimer's Disease
NCT00154076

Completed

A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies

Conditions: Epilepsy
NCT01023867

Completed

Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia

Conditions: Alzheimer's Disease; Dementia
NCT01023425

Completed

Clinical Trial of Donepezil Between the Naive Group and the Switching Group

Conditions: Alzheimer's Disease; Dementia
NCT04061863

Recruiting

Nivolumab and Eribulin in HER2 Negative Metastatic Breast Cancer

Conditions: Metastatic Breast Cancer